(Q53031010)

10 May 2018

title

Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era. (English)

1 reference

10 May 2018

0 references

3

1 reference

10 May 2018

author name string

Naresh V Desireddi

1

1 reference

10 May 2018

Kimberly A Roehl

2

1 reference

10 May 2018

Xiaoying Yu

4

1 reference

10 May 2018

Christopher R Griffin

5

1 reference

10 May 2018

Shilajit K Kundu

6

1 reference

10 May 2018

Misop Han

7

1 reference

10 May 2018

William J Catalona

8

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 November 2007

1 reference

10 May 2018

published in

Urology

1 reference

10 May 2018

volume

70

1 reference

10 May 2018

issue

5

1 reference

10 May 2018

page(s)

950-955

1 reference

10 May 2018

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Impotence following radical prostatectomy: insight into etiology and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Histologic grading of prostate cancer: a perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Prostate cancer and the Will Rogers phenomenon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.06.1119

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2007.06.1119

1 reference

10 May 2018

PubMed ID

18068453

1 reference

10 May 2018